Except NF‐κB signaling, many other signaling pathways are also involved in the complex interactions between TME and cancer cells, such as Wnt/β‐catenin signaling and Notch signaling (Yang et al., 2018; Ye et al., 2019). The gene discussed is NFKB1; the disease is cancer.